Baird Financial Group’s Terns Pharmaceuticals TERN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-13,665
Closed -$37.7K 1853
2025
Q1
$37.7K Sell
13,665
-355
-3% -$980 ﹤0.01% 1741
2024
Q4
$77.7K Sell
14,020
-189
-1% -$1.05K ﹤0.01% 1728
2024
Q3
$119K Buy
+14,209
New +$119K ﹤0.01% 1696